Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 902 of 1,261
  1. US 2012263625

    GLYCO-SUBSTITUTED DIHYDROXY-CHLORINS AND ß-FUNCTIONALIZED CHLORINS FOR ANTI-MICROBIAL PHOTODYNAMIC THERAPY

    AICHER DANIEL [DE] · Granted Oct 18, 2012 · Expires Oct 13, 2032

    granted
  2. EP 2511275

    Neuartige Piperidinyl-monocarboxylsäuren als S1P1 Rezeptoragonisten

    BIOPROJET SOC CIV [FR] · Granted Oct 17, 2012 · Expires Oct 12, 2032

    granted
  3. US 8288536

    Kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted
  4. US 8288359

    Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted
  5. US 8287857

    Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted
  6. US 8288382

    Diaminothiazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted
  7. US 8287879

    Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use

    The Regents of the University of California · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted
  8. US 8288539

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted
  9. US 8288537

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted
  10. US 8288550

    Crystalline form of a benzimidazole-carboxamide medicinal compound

    Theravance, Inc. · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted
  11. US 8288530

    Method of preparing macromolecular contrast agents and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted
  12. US 8288400

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted
  13. US 8288390

    Benzofuran derivatives

    Takeda Pharmaceutical Company Limited · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted
  14. US 8288525

    Compositions and methods for inhibiting expression of CD45 gene

    Alnylam Pharmaceuticals, Inc. · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted
  15. US 8288439

    Methods and compositions for the inhibition of HIV-1 replication

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted
  16. US 8288342

    Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetate

    TEVA WOMEN'S HEALTH, INC. · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted
  17. US 8287876

    Recombinant chimeric antigens for diagnosis and prevention of scrub typhus

    United States of America as represented by the Secretary of the Air Force · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted
  18. US 8287819

    Device for synthesis of radiopharmaceutical products

    Ion Beam Applications · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted
  19. US 2012259187

    DYNAMIC COLORECTAL PDT APPLICATION

    KRUIJT BASTIAAN [NL] · Granted Oct 11, 2012 · Expires Oct 6, 2032

    granted
  20. US 2012255544

    BEPOTASTINE COMPOSITIONS

    PADILLA ANGEL [US] · Granted Oct 11, 2012 · Expires Oct 6, 2032

    granted
  21. US 8282937

    Cold-adapted (CA) reassortant influenza virus

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 9, 2012 · Expires Oct 4, 2032

    granted
  22. US 8282963

    Methods for extracting platelets and compositions obtained therefrom

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 9, 2012 · Expires Oct 4, 2032

    granted
  23. US 8283342

    Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one as agonist of the β2 adrenergic receptor

    Almirall, S.A. · Granted Oct 9, 2012 · Expires Oct 4, 2032

    granted
  24. US 8283377

    Method for inhibiting blood vessel stenosis

    China Medical University · Granted Oct 9, 2012 · Expires Oct 4, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.